Sign inJoin waitlistJoin the waitlist

Anna Nolan

Director, Research Oversight, Bellevue Hospital Center · NYU Grossman School of Medicine

Credentials: · · · · ·

History

Research Oversight · NYU Grossman School of Medicine
Present
NYU Grossman School of Medicine
Present

Pulmonary Disease and Critical Care Medicine
NYU Grossman School of Medicine
2000–2003
SAINT LUKES ROOSEVELT HOSPITAL
1996–1999
SUNY Downstate University Health Sciences University College of Medicine
1992–1996

Research

Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19
Stem Cells and Development · 2020 · 557 citations
A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens
Critical Care Medicine · 2007 · 134 citations
Quantitative lung morphology: semi-automated measurement of mean linear intercept
BMC Pulmonary Medicine · 2019 · Last of 9 authors · Corresponding · 110 citations

David Prezant
49 papers
Sophia Kwon
49 papers · 35 as a resident
Michael Weiden
46 papers
William Rom
19 papers
TA
Thomas Aldrich
15 papers
KK
Kerry Kelly
11 papers
AC
Ashley Comfort
8 papers
MM
Mena Mikhail
7 papers · 6 as a resident
GE
Ghislaine Echevarria
6 papers
SP
Sanjiti Podury
6 papers · 4 as a resident
Soo Cho
6 papers
Edward Schenck
4 papers · 1 as a fellow

Grants

Translation of the Aging and Immunity Multiome (TAIM): A Pilot Lifestyle Investigation in WTC Exposed FDNY Responders
NIOSH · R21
Contact PI · $500K · New York University School of Medicine
2025–2027
Metabolomics of World Trade Center-Lung Injury: Biomarker Validation, Longitudinal Assessment and Dietary Intervention
NIOSH · U01
Contact PI · $4.8M · New York University School of Medicine
2017–2026
World Trade Center Particulate Matter Induced Cardiorespiratory and Vascular Dysfunction: A MultiOmic Approach
NIOSH · U01
Contact PI · $3M · New York University School of Medicine
2021–2026
Aerodigestive Disease in the World Trade Center Exposed FDNY Cohort: Validation of Biomarkers and Defining Risk to Tailor Therapy
NIOSH · U01
Contact PI · $2.2M · New York University School of Medicine
2021–2026

Clinical trials

World Trade Center Particulate Matter Induced Cardiorespiratory and Vascular Dysfunction: a MultiOmic Approach (CaRVD)
Principal investigator · Recruiting
NYU Langone Health
2023–2027
Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BADBURN)
Principal investigator · Enrolling by invitation
NYU Langone Health
2023–2027
Food Intake REstriction for Health OUtcome Support and Education (FIREHOUSE) Trial
Principal investigator · Completed
NYU Langone Health
2018–2021